mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.4 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.4 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.4 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.4 |